Literature DB >> 8229050

Onset, natural history and outcome in idiopathic adult motor neuron disease.

F Norris1, R Shepherd, E Denys, K U, E Mukai, L Elias, D Holden, H Norris.   

Abstract

Cases of adult-onset idiopathic motor neuron disease (MND) identified from January 1970 through December 1986 were studied in a defined area of California. The patients were followed prospectively throughout the illness in 99% of cases. Among 708 cases aged 25-74 years at onset, the most common type (86%) was typical, sporadic amyotrophic lateral sclerosis (SporALS). The risk of bulbar onset and shorter survival times increased with age in both men and women. About 4%, mainly younger men, experienced unusually long courses with milder paralysis, but could not be identified early in the illness. They probably represent one extreme of the ALS spectrum rather than a distinct subtype. Familial ALS (FamALS) was diagnosed in 7%. It developed earlier in life but ran a slightly longer course, which suggests a different disease process. Overall there was a statistically significant predominance of males, especially in 17 cases (2%) of progressive muscular atrophy (PMA). There were 26 cases (4%) classified as primary lateral sclerosis (PLS). Progressive bulbar palsy was not found; that diagnosis usually denotes merely the bulbar onset of ALS.

Entities:  

Mesh:

Year:  1993        PMID: 8229050     DOI: 10.1016/0022-510x(93)90245-t

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  59 in total

1.  ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis.

Authors:  A Chiò
Journal:  J Neurol       Date:  1999-11       Impact factor: 4.849

2.  Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004.

Authors:  Farrah J Mateen; Marco Carone; Eric J Sorenson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-13       Impact factor: 10.154

Review 3.  Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Jeffrey M Statland; Richard J Barohn; April L McVey; Jonathan S Katz; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 4.  Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis).

Authors:  Omar Jawdat; Jeffrey M Statland; Richard J Barohn; Jonathan S Katz; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 5.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

Review 6.  Gender differences in neurological disease: role of estrogens and cytokines.

Authors:  Anna Członkowska; Agnieszka Ciesielska; Grazyna Gromadzka; Iwona Kurkowska-Jastrzebska
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

7.  Prognosis of amyotrophic lateral sclerosis with respiratory onset.

Authors:  Christen L Shoesmith; Karen Findlater; Ann Rowe; Michael J Strong
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-06       Impact factor: 10.154

8.  Management of symptoms in amyotrophic lateral sclerosis.

Authors:  Lisa S Thibodeaux; Amparo Gutierrez
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

9.  Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings.

Authors:  J Kuipers-Upmeijer; A E de Jager; J M Hew; J W Snoek; T W van Weerden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

10.  Corticoefferent pathways in pure lower motor neuron disease: a diffusion tensor imaging study.

Authors:  Angela Rosenbohm; Hans-Peter Müller; Annemarie Hübers; Albert C Ludolph; Jan Kassubek
Journal:  J Neurol       Date:  2016-09-13       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.